Logo Logo
Help
Contact
Switch language to German
The addition of the novel heparan sulfate (HS) mimetic PG545 to standard chemotherapy shows promising efficacy in the treatment of ovarian cancer in vitro and in vivo
The addition of the novel heparan sulfate (HS) mimetic PG545 to standard chemotherapy shows promising efficacy in the treatment of ovarian cancer in vitro and in vivo
Not available
Not available
Freyer, Luisa
2018
English
Universitätsbibliothek der Ludwig-Maximilians-Universität München
Freyer, Luisa (2018): The addition of the novel heparan sulfate (HS) mimetic PG545 to standard chemotherapy shows promising efficacy in the treatment of ovarian cancer in vitro and in vivo. Dissertation, LMU München: Faculty of Medicine
[img]
Preview
PDF
Freyer_Luisa.pdf

6MB